These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3165722)

  • 21. Novel antibacterial class: a series of tetracyclic derivatives.
    Hinman MM; Rosenberg TA; Balli D; Black-Schaefer C; Chovan LE; Kalvin D; Merta PJ; Nilius AM; Pratt SD; Soni NB; Wagenaar FL; Weitzberg M; Wagner R; Beutel BA
    J Med Chem; 2006 Aug; 49(16):4842-56. PubMed ID: 16884296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of antimicrobial agents. V. Synthesis and antimicrobial activities of some heterocylic condensed 1,8-naphthyridine derivatives.
    Suzuki N
    Chem Pharm Bull (Tokyo); 1980 Mar; 28(3):761-8. PubMed ID: 7389031
    [No Abstract]   [Full Text] [Related]  

  • 23. Differentiation of Mycobacterium gordonae from Mycobacterium scrofulaceum and Mycobacterium szulgai by susceptibility to enoxacin (antimycobacterial activity of enoxacin).
    Tsukamura M
    Microbiol Immunol; 1986; 30(9):931-3. PubMed ID: 3467156
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis and in vitro antibacterial activity of gemifloxacin derivatives containing a substituted benzyloxime moiety.
    Feng L; Lv K; Liu M; Wang S; Zhao J; You X; Li S; Cao J; Guo H
    Eur J Med Chem; 2012 Sep; 55():125-36. PubMed ID: 22841282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents.
    Wise R; Andrews JM; Danks G
    J Antimicrob Chemother; 1984 Mar; 13(3):237-44. PubMed ID: 6586712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and antibacterial activity of naphthyridone derivatives containing mono/difluoro-methyloxime pyrrolidine scaffolds.
    Lv K; Liu ML; Feng LS; Sun LY; Sun YX; Wei ZQ; Guo HQ
    Eur J Med Chem; 2012 Jan; 47(1):619-25. PubMed ID: 22079379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Progress in chemotherapeutic agents--pyridonecarboxylic acid].
    Matsumoto F; Hirabayashi T
    Nihon Rinsho; 1986 Apr; 44(4):841-5. PubMed ID: 3761590
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthesis and biological evaluation of benzo[b]naphthyridones, a series of new topical antibacterial agents.
    Tabart M; Picaut G; Desconclois JF; Dutka-Malen S; Huet Y; Berthaud N
    Bioorg Med Chem Lett; 2001 Apr; 11(7):919-21. PubMed ID: 11294391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The in-vitro activity of EN 272, a quinolone-7-carboxylic acid, in comparison with other quinolones.
    Neu HC
    J Antimicrob Chemother; 1985 Jul; 16(1):43-8. PubMed ID: 3862659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro sensitivity of legionellas, meningococci and mycoplasmas to ciprofloxacin and enoxacin.
    Fallon RJ; Brown WM
    J Antimicrob Chemother; 1985 Jun; 15(6):787-9. PubMed ID: 3161857
    [No Abstract]   [Full Text] [Related]  

  • 31. [Enoxacin and ciprofloxacin: in vitro effect on Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus].
    Roy C; Foz A; Segura C; Tirado M; Teixell M; Teruel D
    Med Clin (Barc); 1986 Jan; 86(1):1-3. PubMed ID: 2937983
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM; Baltch AL; Smith RP
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free-Wilson analysis of the antibacterial activity of fluoronaphthyridines against various microbes. A new application of indicator variables.
    Terada Y; Nanya K
    Pharmazie; 2000 Feb; 55(2):133-5. PubMed ID: 10723773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro antimicrobial activity of CI-919 against gram-negative bacilli and Staphylococcus aureus isolated from various pathologies].
    Prado V; Reyes L
    Rev Med Chil; 1985 Feb; 113(2):94-102. PubMed ID: 3866270
    [No Abstract]   [Full Text] [Related]  

  • 35. The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients.
    Guimaraes MA; Noone P
    J Antimicrob Chemother; 1986 Jan; 17(1):63-7. PubMed ID: 2936708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of left-hand-side moiety (Part-2).
    Singh SB; Kaelin DE; Wu J; Miesel L; Tan CM; Black T; Nargund R; Meinke PT; Olsen DB; Lagrutta A; Lu J; Patel S; Rickert KW; Smith RF; Soisson S; Sherer E; Joyce LA; Wei C; Peng X; Wang X; Fukuda H; Kishii R; Takei M; Takano H; Shibasaki M; Yajima M; Nishimura A; Shibata T; Fukuda Y
    Bioorg Med Chem Lett; 2015 May; 25(9):1831-5. PubMed ID: 25851938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The activity of enoxacin against clinical bacterial isolates in comparison with that of five other agents, and factors affecting that activity.
    Reeves DS; Bywater MJ; Holt HA
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():7-17. PubMed ID: 6594324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low frequency of bacterial resistance to enoxacin in vitro and in experimental pneumonia.
    Scribner RK; Welch DF; Marks MI
    J Antimicrob Chemother; 1985 Nov; 16(5):597-603. PubMed ID: 3865924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Target-directed synthesis of antibacterial drug candidate GSK966587.
    Voight EA; Yin H; Downing SV; Calad SA; Matsuhashi H; Giordano I; Hennessy AJ; Goodman RM; Wood JL
    Org Lett; 2010 Aug; 12(15):3422-5. PubMed ID: 20670007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluoronaphthyridines and -quinolones as antibacterial agents. 3. Synthesis and structure-activity relationships of new 1-(1,1-dimethyl-2-fluoroethyl), 1-[1-methyl-1-(fluoromethyl)-2-fluoroethyl], and 1-[1,1-(difluoromethyl)-2-fluoroethyl] substituted derivatives.
    Remuzon P; Bouzard D; Cesare PD; Essiz M; Jacquet JP; Kiechel JR; Ledoussal B; Kessler RE; Fung-Tomc J
    J Med Chem; 1991 Jan; 34(1):29-37. PubMed ID: 1992128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.